MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 66 filers reported holding MARKER THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $223,143 | -73.7% | 314,286 | -90.0% | 0.11% | -80.9% |
| Q4 2022 | $848,571 | -27.0% | 3,142,857 | 0.0% | 0.56% | -27.5% |
| Q3 2022 | $1,163,000 | +12.2% | 3,142,857 | 0.0% | 0.77% | +4.3% |
| Q2 2022 | $1,037,000 | -25.0% | 3,142,857 | 0.0% | 0.74% | -0.8% |
| Q1 2022 | $1,383,000 | -53.7% | 3,142,857 | 0.0% | 0.75% | -29.2% |
| Q4 2021 | $2,986,000 | -43.8% | 3,142,857 | 0.0% | 1.05% | -0.6% |
| Q3 2021 | $5,311,000 | -39.4% | 3,142,857 | 0.0% | 1.06% | -24.6% |
| Q2 2021 | $8,769,000 | +24.6% | 3,142,857 | 0.0% | 1.40% | +10.8% |
| Q1 2021 | $7,040,000 | +142.8% | 3,142,857 | +57.1% | 1.27% | +154.4% |
| Q4 2020 | $2,900,000 | -3.3% | 2,000,000 | 0.0% | 0.50% | -48.0% |
| Q3 2020 | $3,000,000 | -27.5% | 2,000,000 | 0.0% | 0.96% | -39.4% |
| Q2 2020 | $4,140,000 | +8.9% | 2,000,000 | 0.0% | 1.58% | -4.5% |
| Q1 2020 | $3,800,000 | -34.0% | 2,000,000 | 0.0% | 1.66% | -25.0% |
| Q4 2019 | $5,760,000 | -43.6% | 2,000,000 | 0.0% | 2.21% | -58.6% |
| Q3 2019 | $10,220,000 | -35.5% | 2,000,000 | 0.0% | 5.33% | -21.2% |
| Q2 2019 | $15,840,000 | +20.0% | 2,000,000 | 0.0% | 6.76% | -32.7% |
| Q1 2019 | $13,200,000 | +18.9% | 2,000,000 | 0.0% | 10.06% | -14.0% |
| Q4 2018 | $11,100,000 | – | 2,000,000 | – | 11.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |